TORONTO, May 13 /PRNewswire-FirstCall/ - Microbix Biosystems Inc. (MBX:TSX), a biotechnology company focused on virology and biological technologies, reported sales for the second fiscal quarter of 2010 of $1.83 million, a 17% increase, and a record sales level for the 20-year-old biotech company. If not for the strong Canadian dollar, sales would have increased by 36%.